Us2.ai vs KardiaPro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Us2.ai

by Us2.ai

KardiaPro

by AliveCor

AI Verdict

Us2.ai focuses on automating the analysis of echocardiograms, providing detailed cardiac measurements and disease detection from ultrasound images. In contrast, KardiaPro is designed for remote patient monitoring, managing and analyzing ECG, blood pressure, and weight data collected over time. While both tools leverage AI for cardiac insights and are FDA-cleared, Us2.ai is geared towards point-in-time diagnostic imaging analysis, whereas KardiaPro supports continuous patient oversight and trend analysis.

Choose Us2.ai if…

Choose Us2.ai if your cardiology department needs to significantly reduce the manual effort and time spent on echocardiogram analysis and reporting. This tool is ideal for high-volume echo labs, hospitals, and clinical trials seeking fully automated, zero-click structured reports, real-time processing, and AI-driven detection of various cardiac conditions like amyloidosis, heart failure, and aortic stenosis, directly integrating with existing PACS, CVIS, and EMR systems.

View Us2.ai →

Choose KardiaPro if…

Choose KardiaPro if your practice focuses on remote patient monitoring and requires a comprehensive platform to manage and review patient ECG, blood pressure, and weight data between appointments. This tool is best suited for cardiologists, family medicine, and internal medicine specialists who need FDA-cleared AI for arrhythmia detection, customizable ECG inboxes for efficient data review, and automated summary reports to track longitudinal cardiac patterns and make informed clinical decisions for improved patient care.

View KardiaPro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Us2.ai	KardiaPro
Pricing	Contact for pricing	Contact for pricing
Deployment	Cloud or on-premise deployment options	Cloud-hosted, Web-based
FDA Status	1 AI-estimated	1 AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Us2.ai	KardiaPro
Tool Name	Us2.ai	KardiaPro
Company	Us2.ai	AliveCor
Description	FDA-cleared AI software that automates echocardiogram analysis, generating structured reports and detecting cardiac conditions like amyloidosis for clinicians, significantly reducing manual effort and improving diagnostic efficiency.	Comprehensive web-based portal for remote monitoring of patient ECG, blood pressure, and weight data, with FDA-cleared AI for arrhythmia detection and other cardiac determinations.
Key Features (Primary Function)	Fully automated echocardiography analysis, zero-click structured reports, automated disease detection (e.g., cardiac amyloidosis, heart failure)	Remote monitoring of ECG, blood pressure, and weight data, FDA-cleared AI for arrhythmia detection
Specialties	Cardiology, Critical Care, Emergency Medicine	Cardiology, Family Medicine, Internal Medicine
Integration	PACS, CVIS, EMR, and ultrasound devices (DICOM, HL7)	KardiaMobile and KardiaMobile 6L devices, KardiaStation

Videos

Demos, reviews, and walkthroughs featuring Us2.ai and KardiaPro.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems?

Us2.ai integrates with PACS, CVIS, EMR, and ultrasound devices via DICOM and HL7, processing echocardiograms in real-time and delivering structured reports directly into the reading workflow. KardiaPro, a web-based portal, integrates with KardiaMobile devices and can integrate with EHR systems like Epic via its App Orchard Marketplace, allowing providers to access medical-grade heart data within their existing workflows.

What is the accuracy and sensitivity of each tool's disease detection capabilities?

Us2.ai's automated measurements have been validated in peer-reviewed studies, showing agreement with expert readers for various cardiac conditions and achieving 93% sensitivity and 90% accuracy in detecting cardiac amyloidosis when integrated with clinical data. KardiaPro's FDA-cleared AI for arrhythmia detection, specifically for AFib, has demonstrated 96.6% sensitivity and 94% specificity compared to cardiology over-read of 12-lead EKGs.

What is the typical learning curve for physicians and sonographers using these tools?

Us2.ai aims for a minimal learning curve by offering fully automated, zero-click analysis that integrates into existing infrastructure without changing how studies are acquired. This allows sonographers to focus on image acquisition, and physicians to review editable AI outputs and annotations. KardiaPro, as a web-based portal for remote monitoring, is designed for efficient data review and trend visualization, suggesting a user-friendly interface for healthcare professionals.

What kind of audit trail features are available to ensure accountability and transparency?

Us2.ai offers an automated core lab solution with a structured four-stage QA process and an audit log, particularly useful for clinical trials and retrospective analysis. KardiaPro, as a secure web-based platform, manages and reviews patient data, and its SOC-2 certification indicates robust security controls, which typically include audit logging.

How do these tools support multi-site rollouts and enterprise-level deployments?

Us2.ai is designed for enterprise-wide deployment, offering both cloud and on-premise options, and integrates with existing PACS, CVIS, and EMR systems via standard DICOM routing. It can also be deployed through AI marketplaces, facilitating broader adoption within health systems. KardiaPro is a comprehensive web-based portal for remote monitoring, suggesting scalability for managing data from numerous patients across different locations.

Beyond HIPAA, what additional security measures are in place to protect patient data?

Us2.ai is ISO 27001:2022 certified, SOC 2 Type II audited, and MDSAP certified, demonstrating adherence to international standards for information security management and medical device quality. KardiaPro is SOC-2 certified and ISO 27001 compliant, indicating strong security controls and an established information security management system.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Us2.ai or KardiaPro

Backers

Who funded each tool's parent company.